12-11-2026 12:43 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 406.24
NSE Code AUROPHARMA
Dividend Yield % 0.22
Market Cap 1034558.22
P/E 37.83
EPS 47.54
Face Value 1  
Description ( As On September 2026 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  280807385  48.8  280807385  
  Foreign Promoter  1  17690341  3.07  17690341  
  Total Promoter  14  298497726  51.88  298497726  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  44  93868012  16.31  93868012  
  FI/Bank/Insurance  28  28265543  4.91  28265543  
  Govt          
  FII          
  Other  796  118567283  20.61  118567283  
  Total Institutions  868  240700838  41.83  240700838  
 Non-Institution          
  Bodies Corporate  1661  3414985  0.59  3413875  
  Individuals          
  NRIs/OCBs  7899  2052698  0.36  2052698  
  Others  223295  30711648  5.34  30143598  
  Total Non-Institution  232855  36179331  6.29  35610171  
Total Non Promoter  233723  276880169  48.12  276311009  
          
  Depository Receipts          
          
Grand Total  233737  575377895  100  574808735  
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.